IJR News — today's news from every sideDerek Foss This shows why the FDA should have kept tighter controls on these pills instead of loosening rules. Sam Okafor The pattern of claims since 2021 suggests the changes removed important safeguards that used to be in place. Jared Kim These cases show why access to medication shouldn't come without proper safeguards in place. Jared Kim Any woman forced into taking those pills deserves a full investigation regardless of the policy shift. Dana Whitfield These cases prove the regulations should have kept more medical oversight to prevent abuse of vulnerable women. Jared Kim The FDA should bring back tighter controls so no one gets pressured into taking them. Priya Raman If these lawsuits hold up it shows the FDA rule change went too far without enough safeguards for patients. Dana Whitfield Regulators should look at adding safeguards since the relaxed rules are tied to rising coercion claims. Rachel Meyers Stricter verification should have been kept in place to protect anyone vulnerable to being forced into this. Jared Kim If these forced cases keep piling up, the regulations need to be tightened again to protect vulnerable women. Marcus Bell Better oversight on pill distribution might prevent situations where women end up suing over forced procedures. Elena Vasquez The lawsuits raise valid questions about whether safety standards were lowered too far for these medications. Derek Foss Courts need to examine these cases closely to see what safeguards failed after the dispensing rules were relaxed.